This was the stock's second consecutive day of gains.

Bio-Techne (TECH) is back in focus after a recent analyst downgrade that cited softer organic growth and a weaker free cash ...

Bio-Techne faces near-term growth headwinds from challenges in academic and biotech research funding, but retains strong leverage to growing spatial biology, proteomics, and cell/gene therapy research ...

Bio-Techne Corporation today announced that management will host a conference call and webcast on Wednesday, February 4, 2026, at 8:00 a.m. CST to review its second quarter fiscal 2026 financial ...

The leading life sciences reagents and instruments company is expected to announce its fiscal second-quarter earnings for ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

During 2025, Mairs & Power Balanced Fund underperformed its benchmark by 6.91% due to equity underperformance. Read more here ...

The Cord Blood Council (CBC), a new capacity building nonprofit, has launched to support the nation's public cord blood banks. The organization develops and provides shared resources to National Cord ...

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, ...

The region’s hub of diagnostics and testing firms saw a slight increase in employment for the first time in four years, ...

The Global Alzheimer's Platform Foundation(R) (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering wash-free ultrasensitive immunoassay technology, to the Bio-Hermes-002 study.